Skip to main content
Erschienen in: Acta Neurochirurgica 4/2019

19.02.2019 | Original Article - Peripheral Nerves

Long-term outcome after carpal tunnel release and identification of prognostic factors

verfasst von: Floriaan G. C. M. De Kleermaeker, Jan Meulstee, Ronald H. M. A. Bartels, Wim I. M. Verhagen

Erschienen in: Acta Neurochirurgica | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The effectiveness of the surgical treatment of carpal tunnel syndrome (CTS) is well known on short term. However, limited data is available about long-term outcome after carpal tunnel release (CTR). The aims of this study were to explore the long-term outcome after CTR and to identify prognostic factors for long-term outcome.

Methods

Patients with clinically defined CTS underwent CTR and completed the Boston Carpal Tunnel Questionnaire at baseline (T0), at about 8 months (T1), and after a median follow-up of 9 years (T2), as well as a 6-point scale for perceived improvement (at T1 and T2). Potentially prognostic factors were identified by logistic regression analysis and correlation.

Results

At long-term follow-up, 87 patients (40.3%) completed the questionnaires. Mean score on Symptom Severity Scale (2.87 to 1.54; p < 0.001) and Functional Status Scale (2.14 to 1.51; p < 0.001) improved at 8 months and did not change significantly after 8 months. A favorable outcome was reported in 81.6%. A good treatment outcome after 8 months and to a lesser extent a lower FSS score at T0 were associated with a better long-term outcome.

Conclusions

CTR is a robust treatment for CTS and its effect persists after a period of 9 years. The most important factor associated with long-term outcome is treatment outcome after about 8 months and to a lesser extent functional complaints preoperatively. Outcome is independent of patient characteristics, electrodiagnostic test results, or findings at the initial neurological examination.
Literatur
2.
Zurück zum Zitat Bland JD (2001) Do nerve conduction studies predict the outcome of carpal tunnel decompression? Muscle Nerve 24:935–940CrossRefPubMed Bland JD (2001) Do nerve conduction studies predict the outcome of carpal tunnel decompression? Muscle Nerve 24:935–940CrossRefPubMed
5.
Zurück zum Zitat Choi SJ, Ahn DS (1998) Correlation of clinical history and electrodiagnostic abnormalities with outcome after surgery for carpal tunnel syndrome. Plast Reconstr Surg 102:2374–2380CrossRefPubMed Choi SJ, Ahn DS (1998) Correlation of clinical history and electrodiagnostic abnormalities with outcome after surgery for carpal tunnel syndrome. Plast Reconstr Surg 102:2374–2380CrossRefPubMed
9.
Zurück zum Zitat Concannon MJ, Gainor B, Petroski GF, Puckett CL (1997) The predictive value of electrodiagnostic studies in carpal tunnel syndrome. Plast Reconstr Surg 100:1452–1458CrossRefPubMed Concannon MJ, Gainor B, Petroski GF, Puckett CL (1997) The predictive value of electrodiagnostic studies in carpal tunnel syndrome. Plast Reconstr Surg 100:1452–1458CrossRefPubMed
14.
Zurück zum Zitat Kulick MI, Gordillo G, Javidi T, Kilgore ES Jr, Newmayer WL 3rd (1986) Long-term analysis of patients having surgical treatment for carpal tunnel syndrome. J Hand Surg [Am] 11:59–66CrossRef Kulick MI, Gordillo G, Javidi T, Kilgore ES Jr, Newmayer WL 3rd (1986) Long-term analysis of patients having surgical treatment for carpal tunnel syndrome. J Hand Surg [Am] 11:59–66CrossRef
19.
Zurück zum Zitat Luchetti R, Schoenhuber R, Alfarano M, Montagna G, Pederzini L, Soragni O (1991) Neurophysiological assessment of the early phases of carpal tunnel syndrome with the inching technique before and during operation. J Hand Surg (Br) 16:415–419CrossRef Luchetti R, Schoenhuber R, Alfarano M, Montagna G, Pederzini L, Soragni O (1991) Neurophysiological assessment of the early phases of carpal tunnel syndrome with the inching technique before and during operation. J Hand Surg (Br) 16:415–419CrossRef
21.
Zurück zum Zitat Mondelli M, Reale F, Padua R, Aprile I, Padua L (2001) Clinical and neurophysiological outcome of surgery in extreme carpal tunnel syndrome. Clin Neurophysiol 112:1237–1242CrossRefPubMed Mondelli M, Reale F, Padua R, Aprile I, Padua L (2001) Clinical and neurophysiological outcome of surgery in extreme carpal tunnel syndrome. Clin Neurophysiol 112:1237–1242CrossRefPubMed
23.
Zurück zum Zitat Nancollas MP, Peimer CA, Wheeler DR, Sherwin FS (1995) Long-term results of carpal tunnel release. J Hand Surg (Br) 20:470–474CrossRef Nancollas MP, Peimer CA, Wheeler DR, Sherwin FS (1995) Long-term results of carpal tunnel release. J Hand Surg (Br) 20:470–474CrossRef
25.
Zurück zum Zitat Schrijver HM, Gerritsen AA, Strijers RL, Uitdehaag BM, Scholten RJ, de Vet HC, Bouter LM (2005) Correlating nerve conduction studies and clinical outcome measures on carpal tunnel syndrome: lessons from a randomized controlled trial. J Clin Neurophysiol 22:216–221PubMed Schrijver HM, Gerritsen AA, Strijers RL, Uitdehaag BM, Scholten RJ, de Vet HC, Bouter LM (2005) Correlating nerve conduction studies and clinical outcome measures on carpal tunnel syndrome: lessons from a randomized controlled trial. J Clin Neurophysiol 22:216–221PubMed
Metadaten
Titel
Long-term outcome after carpal tunnel release and identification of prognostic factors
verfasst von
Floriaan G. C. M. De Kleermaeker
Jan Meulstee
Ronald H. M. A. Bartels
Wim I. M. Verhagen
Publikationsdatum
19.02.2019
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 4/2019
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-019-03839-y

Weitere Artikel der Ausgabe 4/2019

Acta Neurochirurgica 4/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.